VP22 proteins and uses thereof

Details VP22 proteins and uses thereof VP22 proteins and uses thereof

2006-06-27

2006-06-27

Housel, James C. (Department: 1648)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C530S300000, C530S402000, C514S002600

Reexamination Certificate

active

07067632

ABSTRACT:
Herpesviral VP22 proteins (and variants) are used to modify cell structure and cell division, by their newly found property of binding to microtubules in cells. Uses of VP22 to exploit this property include stabilisation of animal cellular microtubules in vivo and in vitro, e.g. to retard or arrest cell division or induce cell death. The microtubule binding function of VP22 can be exploited by reagent use in vitro to study microtubules or the cell cycle particularly at cell division, and pharmaceutically to retard or arrest cell division of cells such as neoplastic cells or protozoal parasite cells in vitro or in vivo.

REFERENCES:
patent: 4942184 (1990-07-01), Haugwitz et al.
patent: 5272171 (1993-12-01), Ueda et al.
patent: 5356927 (1994-10-01), Taraschi et al.
patent: 5583153 (1996-12-01), Brahn
patent: 5621001 (1997-04-01), Canetta et al.
patent: 5631278 (1997-05-01), Taraschi et al.
patent: 6017735 (2000-01-01), O'Hare et al.
patent: 6184038 (2001-02-01), O'Hare et al.
patent: 6251398 (2001-06-01), O'Hare et al.
patent: 0 473 326 (1992-03-01), None
patent: 0 505 047 (1992-09-01), None
patent: 0 537 905 (1993-04-01), None
patent: 0 558 959 (1993-09-01), None
patent: 0 584 001 (1994-02-01), None
patent: WO 89/08453 (1989-09-01), None
patent: WO 90/10443 (1990-09-01), None
patent: WO 93/02065 (1993-02-01), None
patent: WO 93/14787 (1993-08-01), None
patent: WO 94/12172 (1994-06-01), None
patent: WO 97/05265 (1997-02-01), None
“Herpesvirisdae”, MeSH Browser, www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=mesh.
Entry for “herpesvirus”, The On-line Medical Dictionary, cancerweb.ncl.ac.uk/omd/.
Benet et al.,The Pharmacological Basis of Therapeutics,8thed., pp. 3-266, McGraw Hill, Inc., New York, New York, 1990.
De Arruda et al.,Cancer Research55(14):3085-3092, 1995.
Dermer,Bio/Technology12:320, 1994.
Elliott et al.,J. Gen. Virol.73:723-726,1992.
Elliott et al.,Cell83:223-233, 1997.
Jain,Cancer Research and Metastasis Reviews9:253-266, 1990.
Jain,Science271:1079-1080, 1996.
Mandelkow et al.,Neurobiology of Aging16(3):355-363, 1995.
Marshall et al.,Nature Biotechnology15(3):205, 1997.
Piperno et al.,J. Cell Biol.104:289-302, 1987.

Affiliated with

Also associated with

Rating

VP22 proteins and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with VP22 proteins and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VP22 proteins and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3672092